Webcast overview
As the legislative landscape continues to evolve, it is important for companies to stay abreast of current developments as they relate to relevant tax credit and incentive opportunities. The United States Inflation Reduction Act (IRA), as an example, includes over $350 million in new and expanded clean energy tax credits. Life Sciences companies looking to understand the applicability, timing, and process for disbursements of the relevant incentives, including the refundability / transferability mechanisms now available, would benefit from this industry focused discussion. It is beneficial for companies to understand not only the full landscape of these federal credit and incentive changes but also incentive opportunities provided by other jurisdictions including states, localities, and other countries.
Please join us for our upcoming webcast, where KPMG professionals will discuss a variety of topics, including:
Overview of the IRA credits as applicable to the life sciences industry
- ESG/clean energy tax provisions
- Qualified small business research & development tax credit
Section 174 research & experimental expenditures
- Mandatory capitalization impacts and opportunities
Other ESG/R&D tax credits and incentives for the life sciences industry
- Non-tax grants and loans
- State
- Global
Objectives:
- Provide an overview of IRA credits applicable to the life sciences industry and how these credits support a life science company’s ESG strategy, goals and objectives
- Discuss how the life science industry and emerging biopharmaceutical companies may benefit from other funding mechanisms potentially available
- Discuss the global R&D incentive landscape and impacts to the life sciences industry
